- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.02. | Range Impact, Inc.: Großaktionär Joseph E. LoConti erwirbt Aktien für 1.000 US-Dollar | - | Investing.com Deutsch | ||
| 23.01. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
| 23.01. | Joseph LoConti von Range Impact erwirbt Stammaktien im Wert von 499.999 US-Dollar | 1 | Investing.com Deutsch | ||
| 19.12.24 | RANGE IMPACT, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 04.12.24 | RANGE IMPACT, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 14.11.24 | RANGE IMPACT, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11.24 | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| 15.10.24 | Range Impact revises Q1 financials due to accounting error | 1 | Investing.com | ||
| 15.10.24 | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| 15.10.24 | RANGE IMPACT, INC. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
| 07.10.24 | Range Impact, Inc.: Range Impact Announces Uplisting to the OTCQB Venture Market | 161 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and... ► Artikel lesen | |
| 02.10.24 | Range Impact, Inc.: Range Impact Announces Sale of Cannabinoid Drug Development Business | 138 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
| 29.08.24 | Range Impact, Inc.: Range Impact Announces Sale of Non-Core Assets as Part of Strategic Plan | 259 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
| 14.08.24 | Range Impact, Inc.: Range Impact Reports 2Q 2024 Financial Results | 363 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites... ► Artikel lesen | |
| 15.05.24 | Range Impact, Inc.: Range Impact Reports 1Q 2024 Financial Results | 152 | GlobeNewswire (Europe) | CLEVELAND, OHIO, May 15, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 63,44 | -1,44 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
| AURORA CANNABIS | 4,090 | +0,89 % | Stocks in Play: Aurora Cannabis Inc. | ||
| CANOPY GROWTH | 0,933 | +9,64 % | What's Going On With Canopy Growth Stock? | ||
| TILRAY BRANDS | 0,602 | -1,08 % | Tilray Brands, Inc.: Tilray Successfully Prevails with Dismissal of HEXO Shareholder Lawsuit | NEW YORK and LEAMINGTON, Ontario, March 26, 2025 (GLOBE NEWSWIRE) -- Tilray Brands Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), and its subsidiary HEXO Corporation ("HEXO"), announced the successful... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 448,65 | +0,09 % | DC court backs HHS in rejecting Vertex's proposed fertility support program for Casgevy patients | ||
| TAAT GLOBAL ALTERNATIVES | 0,130 | 0,00 % | TAAT Global Alternatives Inc (2): TAAT to release timing of 2024, Q1 2025 filing April 14 | ||
| CRONOS GROUP | 1,643 | -2,09 % | Cronos Group Inc.: Cronos Appoints Anna Shlimak as Chief Financial Officer | TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced the appointment of Anna... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc: Digicann Ventures extends debentures | ||
| EYEPOINT PHARMACEUTICALS | 5,080 | +1,28 % | What is Chardan Capital's Forecast for EYPT FY2026 Earnings? | ||
| ORGANIGRAM GLOBAL | 0,931 | -0,75 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 01.04.2025 | Das Instrument 0OG0 CA68620P7056 ORGANIGRAM HLDGS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 01.04.2025 und ex Kapitalmassnahme am 02.04.2025 The instrument 0OG0 CA68620P7056 ORGANIGRAM HLDGS... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 5,235 | -2,15 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2024 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Mydecine Innovations Group Inc (2): Mydecine appoints Field, Callas as directors; COO quits | ||
| ASTRIA THERAPEUTICS | 4,800 | -2,83 % | Astria Therapeutics, Inc.: Astria Therapeutics beginnt Phase-3-Zulassungsstudie ALPHA-ORBIT zu Navenibart bei hereditärem Angioödem | -- Studie zum Nachweis der Wirksamkeit und Sicherheit der Verabreichung alle 3 und alle 6 Monate in einem 6-monatigen Behandlungszeitraum --
Astria Therapeutics, Inc. (Nasdaq: ATXS), ein biopharmazeutisches... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 16,118 | +1,74 % | Santhera Pharmaceuticals Holding AG: Santhera schlägt Dr. Melanie Rolli als neues Mitglied des Verwaltungsrats vor | «Ad hoc-Mitteilung gemäss Art. 53 KR»
Pratteln, Schweiz, 27. März 2025 - Santhera Pharmaceuticals (SIX: SANN) schlägt der kommenden Generalversammlung vom 20. Mai 2025 die Wahl von Dr. Melanie... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 17,460 | -2,29 % | Tonix Pharmaceuticals Holding: Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year | CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial... ► Artikel lesen |
RANGE IMPACT INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RANGE IMPACT INC finden Sie auf Wallstreet Online.
